Correlation Between SPASX Dividend and Telix Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both SPASX Dividend and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SPASX Dividend and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SPASX Dividend Opportunities and Telix Pharmaceuticals, you can compare the effects of market volatilities on SPASX Dividend and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SPASX Dividend with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SPASX Dividend and Telix Pharmaceuticals.
Diversification Opportunities for SPASX Dividend and Telix Pharmaceuticals
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between SPASX and Telix is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding SPASX Dividend Opportunities and Telix Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and SPASX Dividend is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SPASX Dividend Opportunities are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of SPASX Dividend i.e., SPASX Dividend and Telix Pharmaceuticals go up and down completely randomly.
Pair Corralation between SPASX Dividend and Telix Pharmaceuticals
Assuming the 90 days trading horizon SPASX Dividend is expected to generate 56.66 times less return on investment than Telix Pharmaceuticals. But when comparing it to its historical volatility, SPASX Dividend Opportunities is 3.7 times less risky than Telix Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Telix Pharmaceuticals is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 1,876 in Telix Pharmaceuticals on September 19, 2024 and sell it today you would earn a total of 698.00 from holding Telix Pharmaceuticals or generate 37.21% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
SPASX Dividend Opportunities vs. Telix Pharmaceuticals
Performance |
Timeline |
SPASX Dividend and Telix Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
SPASX Dividend Opportunities
Pair trading matchups for SPASX Dividend
Telix Pharmaceuticals
Pair trading matchups for Telix Pharmaceuticals
Pair Trading with SPASX Dividend and Telix Pharmaceuticals
The main advantage of trading using opposite SPASX Dividend and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SPASX Dividend position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.SPASX Dividend vs. Srj Technologies Group | SPASX Dividend vs. Techgen Metals | SPASX Dividend vs. Neurotech International | SPASX Dividend vs. Land Homes Group |
Telix Pharmaceuticals vs. Aneka Tambang Tbk | Telix Pharmaceuticals vs. Commonwealth Bank | Telix Pharmaceuticals vs. Commonwealth Bank of | Telix Pharmaceuticals vs. Australia and New |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |